SEC Form 4 · accession 0000899243-18-024028
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jordan G Naydenov
Director
Period of report
Jan 31, 2018
Accepted (ET)
Sep 7, 2018 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F1 | $1.00 | Jan 31, 2018 | D | 66,666 | D | Jul 26, 2017 | Jul 26, 2022 | Common Stock | 66,666 | 0 | D |
| Warrants (right to buy)F1 | $0.75 | Jan 31, 2018 | A | 66,666 | A | Jan 31, 2018 | Jul 26, 2022 | Common Stock | 66,666 | 66,666 | D |
Explanation of responses
- F1The two transactions reported in Table II above involved the amendment of an outstanding warrant to reduce the exercise price from $1 per share to $0.75 per share. The amendment is reported above as the cancellation of the "old" warrant and the acquisition of a new one.